Clinical trial

Translating the ABCS Into HIV Care

NCT03902431

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-09-26

PhaseNA

Study timeline

Study start (actual)2019-09-26Date precision: day

Registry last updated2024-09-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

What this registered study describes

Translating the ABCS Into HIV Care is a interventional study listed under registry identifier NCT03902431. Its last published status is COMPLETED. Registry status does not establish that enrollment is currently open at every study site.

The published record lists 2 condition label(s), 1 intervention label(s), and 4 sponsor/collaborator entry or entries. The structured information below allows these links to be examined individually; intervention registration is not an efficacy claim.

Source: the original ClinicalTrials.gov study record. Always check the protocol, eligibility, dates, results (when posted), and contacts at the original source.

Conditions

HIVunresolved

Cardiovascular Risk Factorunresolved

Interventions

ABCS trainingBEHAVIORAL

Sponsors & collaborators

University of Rochesterlead sponsor

Clinical Directors Networkcollaborator

University of Texascollaborator

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Mapped research locations

RochesterNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03902431 on ClinicalTrials.gov ↗

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.